Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth.

Ann Allergy Asthma Immunol

Division of Allergy and Clinical Immunology, Jeff and Penny Vinik Center for Allergic Diseases Research, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

Published: September 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527614PMC
http://dx.doi.org/10.1016/j.anai.2023.06.017DOI Listing

Publication Analysis

Top Keywords

perioperative mepolizumab
4
mepolizumab aspirin-exacerbated
4
aspirin-exacerbated respiratory
4
respiratory disease
4
disease prevent
4
prevent nasal
4
nasal polyp
4
polyp regrowth
4
perioperative
1
aspirin-exacerbated
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!